abstract |
The present invention relates to progenitor cells, medicaments containing progenitor cells and also uses thereof for specific tissue regeneration. Such processes are required in all medical sectors, in particular in the treatment of cardiovascular, haematological, nephrological, neurological, dermatological, gastroenterological or orthopaedic disorders. The progenitor cells are characterized in that they are transfected with mRNA which codes for a protein which promotes colonization of the progenitor cells in a target tissue and/or the differentiation of the progenitor cells in target cells or target tissue cells. |